Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1987 3
1988 1
1989 11
1990 6
1991 1
1992 7
1993 4
1994 1
1995 4
1996 3
1997 2
1998 2
1999 2
2003 1
2004 2
2005 4
2006 3
2007 1
2008 7
2009 12
2010 16
2011 9
2012 18
2013 11
2014 10
2015 11
2016 21
2017 18
2018 17
2019 11
2020 9
2021 13
2022 13
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Results by year

Filters applied: . Clear all
Page 1
Thyroid cancer.
Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Chen DW, et al. Among authors: newbold k. Lancet. 2023 May 6;401(10387):1531-1544. doi: 10.1016/S0140-6736(23)00020-X. Epub 2023 Apr 3. Lancet. 2023. PMID: 37023783 Review.
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Filetti S, et al. Among authors: newbold k. Ann Oncol. 2019 Dec 1;30(12):1856-1883. doi: 10.1093/annonc/mdz400. Ann Oncol. 2019. PMID: 31549998 Free article. No abstract available.
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ Jr, Di Cristofano A, Foote R, Giordano T, Kasperbauer J, Newbold K, Nikiforov YE, Randolph G, Rosenthal MS, Sawka AM, Shah M, Shaha A, Smallridge R, Wong-Clark CK. Bible KC, et al. Among authors: newbold k. Thyroid. 2021 Mar;31(3):337-386. doi: 10.1089/thy.2020.0944. Thyroid. 2021. PMID: 33728999 Free PMC article.
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, Dutcus CE, de las Heras B, Zhu J, Sherman SI. Schlumberger M, et al. Among authors: newbold k. N Engl J Med. 2015 Feb 12;372(7):621-30. doi: 10.1056/NEJMoa1406470. N Engl J Med. 2015. PMID: 25671254 Free article. Clinical Trial.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.
Lebbink CA, Links TP, Czarniecka A, Dias RP, Elisei R, Izatt L, Krude H, Lorenz K, Luster M, Newbold K, Piccardo A, Sobrinho-Simões M, Takano T, Paul van Trotsenburg AS, Verburg FA, van Santen HM. Lebbink CA, et al. Among authors: newbold k. Eur Thyroid J. 2022 Nov 29;11(6):e220146. doi: 10.1530/ETJ-22-0146. Print 2022 Dec 1. Eur Thyroid J. 2022. PMID: 36228315 Free PMC article.
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.
Filetti S, Durante C, Hartl DM, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Filetti S, et al. Among authors: newbold k. Ann Oncol. 2022 Jul;33(7):674-684. doi: 10.1016/j.annonc.2022.04.009. Epub 2022 Apr 28. Ann Oncol. 2022. PMID: 35491008 Free article. No abstract available.
Molecular genotyping in medullary thyroid cancer.
Newbold K. Newbold K. Curr Opin Oncol. 2023 Jan 1;35(1):10-14. doi: 10.1097/CCO.0000000000000915. Epub 2022 Nov 23. Curr Opin Oncol. 2023. PMID: 36475457 Review.
Management of Invasive Differentiated Thyroid Cancer.
Nixon IJ, Simo R, Newbold K, Rinaldo A, Suarez C, Kowalski LP, Silver C, Shah JP, Ferlito A. Nixon IJ, et al. Among authors: newbold k. Thyroid. 2016 Sep;26(9):1156-66. doi: 10.1089/thy.2016.0064. Epub 2016 Aug 23. Thyroid. 2016. PMID: 27480110 Free PMC article. Review.
Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.
Wadsley J, Ainsworth G, Coulson AB, Garcez K, Moss L, Newbold K, Farnell K, Swain J, Howard H, Beasley M, Weaver A, Wood K, Marshall J, Griffin M, Pascoe A, Du Y, Taprogge J, Flux G, Brown S. Wadsley J, et al. Among authors: newbold k. Thyroid. 2023 Sep;33(9):1119-1123. doi: 10.1089/thy.2022.0707. Epub 2023 Sep 1. Thyroid. 2023. PMID: 37565288 Free PMC article. Clinical Trial. No abstract available.
240 results